1,703
Views
1
CrossRef citations to date
0
Altmetric
Research Article

A mechanism for improved talc pleurodesis via foam delivery

, , , , , & show all
Pages 733-740 | Received 21 Jan 2021, Accepted 23 Feb 2021, Published online: 08 Apr 2021

References

  • Adler RH, Sayek I. (1976). Treatment of malignant pleural effusion: a method using tube thoracostomy and talc. Ann Thorac Surg 22:8–15.
  • Baxter J, Lima TA, Huneke R, et al. (2020). The efficacy of hydrogel foams in talc pleurodesis. J Cardiothorac Surg 15:1–8.
  • Beck TN, Deneka AY, Chai L, et al. (2019). An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion. BMC Cancer 19:1–8.
  • Bhatnagar R, Piotrowska HE, Laskawiec-Szkonter M, et al. (2020). Effect of thoracoscopic talc poudrage vs talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions: a randomized clinical trial. J Am Med Assoc 323:60.
  • De Campos JRM, Vargas FS, De Campos Werebe E, et al. (2001). Thoracoscopy talc poudrage: a 15-year experience. Chest 119:801–6.
  • Genofre EH, Vargas FS, Acencio MM, et al. (2009). Talc pleurodesis: evidence of systemic Inflammatory response to small size talc particles. Respir Med 103:91–7.
  • Kennedy L, Rusch VW, Strange C, et al. (1994). Pleurodesis using talc slurry. Chest 106:342–6.
  • Laub GW, Huneke RB, Kresh JY, et al. (2017). A novel triblock copolymer hydrogel foam delivery system to improve talc pleurodesis efficacy. J Am College Surg 225:e8.
  • Mierzejewski M, Korczynski P, Krenke R, Janssen JP. (2019). Chemical pleurodesis - a review of mechanisms involved in pleural space obliteration. Respir Res 20:1–16.
  • Neragi-Miandoab S. (2006). Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer 54:1–9.
  • Pereira GG, Dimer FA, Guterres SS, et al. (2013). Formulation and characterization of poloxamer 407: thermoreversible gel containing polymeric microparticles and hyaluronic acid. Quim Nova 36:1121–5.
  • Rodriguez-Panadero F, Antony VB. (1997). Pleurodesis: state of the art. Euro Resp J 10:1648–54.
  • Shaw PH, Agarwal R. (2013). Pleurodesis for malignant pleural effusions. Coch Datab Syst Rev 2004:CD002916.
  • Tessari L, Cavezzi A, Frullini A. (2001). Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 27:58–60.
  • Vargas FS, Antonangelo L, Vaz MA, et al. (2003). Pleurodesis induced by intrapleural injection of silver nitrate or talc in rabbits: can it be used in humans? J Pneumologia 29:57–63.
  • Walker-Renard PB, Vaughan LM, Sahn SA. (1994). Chemical pleurodesis for malignant pleural effusions. Ann Internal Med 120:56–64.
  • Xie C, Teixeira LR, McGovern JP, Light RW. (1998). Systemic corticosteroids decrease the effectiveness of talc pleurodesis. Am J Respir Crit Care Med 157:1441–4.